You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Review: no evidence exists that thrombolysis is better than heparin for reducing the risk of recurrent pulmonary embolism and death

Article Text

Article menu
Download PDFPDF
Treatment
Review: no evidence exists that thrombolysis is better than heparin for reducing the risk of recurrent pulmonary embolism and death

https://doi.org/10.1136/ebn.8.2.52

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Wan S, Quinlan DJ, Agnelli G, et al. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials. Circulation 2004;110:744–9.OpenUrlAbstract/FREE Full Text

    Q In patients with acute pulmonary embolism (PE), is initial thrombolysis more effective than heparin for reducing the risk of recurrent PE and death?

    METHODS

    Embedded ImageData sources:

    Medline and EMBASE/Excerpta Medica (1980 to January 2003), Cochrane Library (Issue 1, 2003); and hand searches of reference lists of retrieved articles and abstracts of conference proceedings.

    Embedded ImageStudy selection and assessment:

    published and unpublished randomised controlled trials (RCTs) with proper randomisation that compared thrombolysis with heparin for initial treatment of patients with objectively diagnosed symptomatic PE, and used objective methods to assess clinical outcomes. 2 independent reviewers …

    View Full Text

    Footnotes

    • For correspondence: Dr J W Eikelboom, McMaster Clinic, Hamilton General Hospital, Hamilton, Ontario, Canada. eikelbjmcmaster.ca

    • Source of funding: no external funding.